Who Paid My Doc
Alhemo
Drug Hemophilia
NDC 0169-2084-15
General payments
$342,211
Research payments
$1,297,544
Through program year 2025, $342,211 in general payments and $1,297,544 in research payments were reported against Alhemo (Hemophilia).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
3 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $342,211 | 537 |
| 2025 | Research | $696,832 | 280 |
| 2024 | Research | $600,713 | 4,583 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 30 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 34 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
537 general · 4,863 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.